Skip to main content
TipRanks
Go Ultimate75% OFF

AXIM Biotechnologies (AXIM) Ratios

151 Followers

AXIM Biotechnologies Ratios

AXIM's free cash flow for Q2 2026 was $-8.97K. For the 2026 fiscal year, AXIM's free cash flow was increased by $5.00 and operating cash flow was $-8.97K. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.000.000.030.030.25
Quick Ratio0.000.000.030.030.25
Cash Ratio0.000.000.030.010.18
Solvency Ratio-0.04-0.22-0.65-0.61-1.88
Operating Cash Flow Ratio-0.11-0.13-0.17-0.60-0.96
Short-Term Operating Cash Flow Coverage0.00-11.040.000.00-1.54
Net Current Asset Value$ -14.24M$ -13.87M$ -11.62M$ -8.93M$ -7.03M
Leverage Ratios
Debt-to-Assets Ratio2.711.931.431.341.26
Debt-to-Equity Ratio-0.68-0.64-0.77-1.17-2.87
Debt-to-Capital Ratio-2.17-1.76-3.356.751.53
Long-Term Debt-to-Capital Ratio-2.17-1.66-2.846.891.86
Financial Leverage Ratio-0.25-0.33-0.54-0.87-2.28
Debt Service Coverage Ratio-2.61-3.42-5.34-2.10-5.58
Interest Coverage Ratio-3.86-2.77-2.28-2.48-10.74
Debt to Market Cap2.1410.861.311.230.12
Interest Debt Per Share0.020.020.030.050.06
Net Debt to EBITDA-8.72-2.72-0.89-1.43-0.48
Profitability Margins
Gross Profit Margin0.00%-524.10%100.00%-4701.42%100.00%
EBIT Margin0.00%-4082.30%-17346.32%-49200.36%-25700.44%
EBITDA Margin0.00%-3468.61%-16265.75%-44398.94%-21775.28%
Operating Profit Margin0.00%-2502.31%-6960.98%-52425.60%-13207.09%
Pretax Profit Margin0.00%-4985.19%-20394.96%-70343.09%-26503.98%
Net Profit Margin0.00%-4985.19%-20394.96%-67120.74%-27320.76%
Continuous Operations Profit Margin0.00%-4985.19%-20394.96%-70343.09%-26503.98%
Net Income Per EBT100.00%100.00%100.00%95.42%103.08%
EBT Per EBIT79.04%199.22%292.99%134.18%200.68%
Return on Assets (ROA)-36.25%-101.89%-195.55%-141.43%-310.29%
Return on Equity (ROE)9.18%33.71%105.26%123.45%706.45%
Return on Capital Employed (ROCE)41.24%53.18%148.14%-567.73%-291.16%
Return on Invested Capital (ROIC)41.24%55.79%156.12%-554.34%-180.91%
Return on Tangible Assets-1469.05%-1423.43%-1530.61%-2675.99%-1758.07%
Earnings Yield-28.63%-579.71%-186.30%-129.97%-29.00%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.250.250.000.320.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.300.110.080.31
Asset Turnover0.000.020.010.000.01
Working Capital Turnover Ratio0.00-0.01-0.01-0.00-0.04
Cash Conversion Cycle-1487.42-1482.430.00-1127.440.00
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding1487.421482.430.001127.440.00
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.00-0.00-0.00-0.01-0.02
Free Cash Flow Per Share-0.00-0.00-0.00-0.01-0.02
Dividend Paid and CapEx Coverage Ratio0.00-300.860.00-234.71-49.25
Capital Expenditure Coverage Ratio0.00-300.860.00-234.71-49.25
Operating Cash Flow Coverage Ratio-0.09-0.13-0.17-0.36-0.37
Operating Cash Flow to Sales Ratio0.00-12.14-26.08-230.35-41.13
Free Cash Flow Yield-18.84%-141.59%-23.82%-44.79%-4.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-3.45-0.17-0.54-0.77-3.45
Price-to-Sales (P/S) Ratio0.008.60109.47516.45942.06
Price-to-Book (P/B) Ratio-0.32-0.06-0.57-0.95-24.36
Price-to-Free Cash Flow (P/FCF) Ratio-5.31-0.71-4.20-2.23-22.45
Price-to-Operating Cash Flow Ratio-5.31-0.71-4.20-2.24-22.90
Price-to-Earnings Growth (PEG) Ratio0.050.000.320.01-0.03
Enterprise Value Multiple-12.80-2.96-1.57-2.59-4.80
Enterprise Value11.42M7.25M10.06M10.20M63.22M
EV to EBITDA-12.80-2.96-1.57-2.59-4.80
EV to Sales0.00102.84254.681149.401045.70
EV to Free Cash Flow-16.65-8.45-9.77-4.97-24.92
EV to Operating Cash Flow-16.65-8.47-9.77-4.99-25.42
Tangible Book Value Per Share-0.04-0.04-0.05-0.05-0.05
Shareholders’ Equity Per Share-0.03-0.03-0.03-0.03-0.02
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-0.00-0.01-0.04-0.04-0.13
Tax Burden1.001.001.000.951.03
Interest Burden0.791.221.181.431.03
Research & Development to Revenue0.000.573.1817.324.71
SG&A to Revenue0.0019.220.000.000.00
Stock-Based Compensation to Revenue0.000.005.00124.7918.92
Income Quality0.660.240.130.330.16

Currency in USD